Biotech and Pharmaceuticals
UnitedHealth Collaborates with DOJ on Medicare Billing Practices Investigation: What You Need to Know
UnitedHealth Group is currently under investigation by the Justice Department regarding its Medicare billing practices. This comes as a significant ... Read more
Sarepta Therapeutics Faces 40% Stock Drop: What This Means for the Future of Gene Therapy
Shares of Sarepta Therapeutics tumbled over 30% recently, raising concerns about the future of its gene therapy treatment, Elevidys. The ... Read more
Trump’s Bold Move: Upcoming 200% Tariff on Pharmaceuticals Could Impact Your Wallet!
President Donald Trump has recently announced plans to impose tariffs of up to 200% on pharmaceuticals imported into the U.S. ... Read more
Exciting Breakthrough: Moderna’s Flu Vaccine Shines in Late-Stage Trials, Setting the Stage for a Combined COVID Vaccine
Moderna recently revealed that its new mRNA-based flu vaccine is showing promise. In late-stage trials, it triggered a stronger immune ... Read more
Top U.S. Health Insurers Revamp Approval Process to Enhance Patient Care
Health insurance companies in the U.S. have decided to make prior authorizations easier. These approvals, needed before certain treatments can ... Read more
UnitedHealth Group Stock Dips 18% Amid DOJ Investigation into Alleged Medicare Fraud: What You Need to Know
Shares of UnitedHealth Group dropped over 18% on Thursday after reports emerged that the Department of Justice (DOJ) is investigating ... Read more
Breaking News: UnitedHealth Group CEO Andrew Witty Resigns as Company Suspends Annual Forecast—What It Means for the Future
UnitedHealth Group recently made headlines with the sudden exit of its CEO, Andrew Witty. His departure surprised many and sent ... Read more
Novo Nordisk Shares Surge 7% Amid Predictions of Easing Wegovy Rivalry in 2025
Novo Nordisk recently saw its shares jump nearly 7%. Why? They reported that sales of Wegovy, their weight-loss drug, are ... Read more
Eli Lilly’s Sales Skyrocket 45% Thanks to Weight Loss Drug Demand, Yet Profit Forecast Dips Following Cancer Treatment Acquisition
Eli Lilly recently shared its financial results for the first quarter, highlighting increasing demand for its weight loss and diabetes ... Read more
Novo Nordisk Expands Wegovy Weight Loss Drug Access via Telehealth: Hims & Hers Shares Surge 30%!
Novo Nordisk Expands Wegovy Access through Telehealth Partnerships Novo Nordisk has announced an exciting development for those seeking weight loss ... Read more
